Inventor · disambiguated record
Sandra Zurawski
Also filed as: ZURAWSKI SANDRA · ZURAWSKI SANDRA M
38 granted patents·31 pending applications·465 citations·filing 1986–2024
98Inventor score
Files withBAYLOR RES INSTITUTE17SCHERING CORP14BAYLOR RES INST11INST NAT SANTE RECH MED8BANCHEREAU JACQUES F5
Top patents by PatentIndex Score
69 records- 0197US9234040B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsBAYLOR RES INST·Filed 2013·Granted Jan 12, 2016·26 cites·13 claims
- 0297US9102730B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsBAYLOR RES INST·Filed 2013·Granted Aug 11, 2015·25 cites·8 claims
- 0397US8728481B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BANCHEREAU JACQUES F·Filed 2012·Granted May 20, 2014·30 cites·9 claims
- 0497US8449888B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERARD·Filed 2011·Granted May 28, 2013·35 cites·8 claims
- 0597US8236934B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BANCHEREAU JACQUES F·Filed 2008·Granted Aug 7, 2012·36 cites·44 claims
- 0696US12214034B2Vaccines against HPV and HPV-related diseasesBAYLOR RES INSTITUTE·Filed 2023·Granted Feb 4, 2025·1 cites·17 claims
- 0795US9102734B2Fusion proteins comprising antibody and HPV E6 and E7 antigensZURAWSKI GERARD·Filed 2010·Granted Aug 11, 2015·46 cites·13 claims
- 0895US8586052B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERARD·Filed 2012·Granted Nov 19, 2013·27 cites·10 claims
- 0993US12016915B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BAYLOR RES INSTITUTE·Filed 2021·Granted Jun 25, 2024·1 cites·7 claims
- 1093US11806390B2Fusion proteins comprising an anti-CD40 antibody and cancer antigensBAYLOR RES INSTITUTE·Filed 2021·Granted Nov 7, 2023·2 cites·14 claims
- 1192US11219683B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2020·Granted Jan 11, 2022·2 cites·14 claims
- 1291US11267895B2Nucleic acids encoding anti-CD40 antibodiesBAYLOR RES INSTITUTE·Filed 2020·Granted Mar 8, 2022·2 cites·13 claims
- 1391US10610585B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2018·Granted Apr 7, 2020·3 cites·25 claims
- 1491US2025018025A1Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)BAYLOR RES INSTITUTE·Filed 2024·Application pending·0 cites
- 1590US9562104B2Anti-CD40 antibodiesBANCHEREAU JACQUES F·Filed 2010·Granted Feb 7, 2017·10 cites·20 claims
- 1690US9109011B2Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/NefBANCHEREAU JACQUES F·Filed 2009·Granted Aug 18, 2015·27 cites·5 claims
- 1790US8057798B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERALD·Filed 2008·Granted Nov 15, 2011·30 cites·5 claims
- 1890US2025121048A1Novel vaccines against hpv and hpv-related diseasesBAYLOR RES INSTITUTE·Filed 2024·Application pending·0 cites
- 1989US11717567B2Vaccines against HPV and HPV-related diseasesBAYLOR RES INSTITUTE·Filed 2021·Granted Aug 8, 2023·1 cites·22 claims
- 2089US10286058B2Vaccines against HPV and HPV-related diseasesBAYLOR RES INSTITUTE·Filed 2015·Granted May 14, 2019·6 cites·21 claims
- 2189US6479638B1Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptorSCHERING CORP·Filed 2000·Granted Nov 12, 2002·19 cites·5 claims
- 2288US10683361B2Anti-CD40 antibodiesBAYLOR RES INSTITUTE·Filed 2018·Granted Jun 16, 2020·2 cites·15 claims
- 2387US9339556B2Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)BAYLOR RES INST·Filed 2013·Granted May 17, 2016·8 cites·13 claims
- 2487US5696234AMuteins of mammalian cytokine interleukin-13SCHERING CORP·Filed 1994·Granted Dec 9, 1997·72 cites·11 claims
- 2586US8481314B2Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)BANCHEREAU JACQUES F·Filed 2008·Granted Jul 9, 2013·8 cites·8 claims
- 2683US10722572B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2019·Granted Jul 28, 2020·1 cites·29 claims
- 2783US10087256B2Method of making an anti-CD40 antibodyBAYLOR RES INSTITUTE·Filed 2017·Granted Oct 2, 2018·2 cites·11 claims
- 2883US9315580B2Vaccines directed to langerhans cellsBAYLOR RES INST·Filed 2013·Granted Apr 19, 2016·5 cites·7 claims
- 2983US7999078B2Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptorSCHERING CORP·Filed 2008·Granted Aug 16, 2011·2 cites·24 claims
- 3080US10980869B2Fusion proteins comprising an anti-CD40 antibody and cancer antigensBAYLOR RES INSTITUTE·Filed 2017·Granted Apr 20, 2021·1 cites·7 claims
- 3180US9567401B2Anti-CD40 antibodiesBAYLOR RES INST·Filed 2014·Granted Feb 14, 2017·2 cites·9 claims
- 3278US2022340670A1Anti-cd40 antibodies and uses thereofBAYLOR RES INSTITUTE·Filed 2022·Application pending·0 cites
- 3377US6676939B2Methods of modulating IL-174 responseSCHERING CORP·Filed 2001·Granted Jan 13, 2004·7 cites·5 claims
- 3470US7357924B2Uses of IL-174 for treating helminth infectionsSCHERING CORP·Filed 2003·Granted Apr 15, 2008·3 cites·3 claims
- 3569US10940195B2Vaccines against HPV and HPV-related diseasesBAYLOR RES INSTITUTE·Filed 2019·Granted Mar 9, 2021·0 cites·19 claims
- 3668US5017692ATruncated human interleukin-a alphaSCHERING CORP·Filed 1986·Granted May 21, 1991·19 cites·1 claims
- 3767US11957734B2Methods and compositions for treating autoimmune and inflammatory conditionsBAYLOR RES INSTITUTE·Filed 2021·Granted Apr 16, 2024·0 cites·20 claims
- 3867US2014141444A1Isolated Mammalian Monocyte Cell Genes; Related ReagentsADEMA GOSSE JAN·Filed 2014·Application pending·0 cites
- 3967US2005059808A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2004·Application pending·0 cites
- 4067US2014141445A1Isolated Mammalian Monocyte Cell Genes; Related ReagentsADEMA GOSSE JAN·Filed 2014·Application pending·0 cites
- 4167US2004143858A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2004·Application pending·0 cites
- 4267US2010136020A1Uses of il-174 antagonists for inhibiting a th2 immune responseSCHERING CORP·Filed 2009·Application pending·0 cites
- 4365US10167339B2Antagonistic anti-OX40L antibodies and methods of their useBAYLOR RES INSTITUTE·Filed 2015·Granted Jan 1, 2019·1 cites·16 claims
- 4465US2025025548A1Universal sarbecovirus vaccinesINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 4564US2013034561A1Isolated mammalian monocyte cell genes; related reagentsMERCK SHARP & DOHME·Filed 2012·Application pending·0 cites
- 4664US2003105303A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2002·Application pending·0 cites
- 4762US2005287582A1Antibodies that specifically bind to FDF03SCHERING CORP·Filed 2005·Application pending·0 cites
- 4862US2009263401A1USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSESCHERING CORP·Filed 2007·Application pending·0 cites
- 4961US2012020990A1Isolated mammalian monocyte cell genes; related reagentsADEMA GOSSE JAN·Filed 2011·Application pending·0 cites
- 5059US2024124532A1Chlamydia trachomatis antigenic polypeptides and uses thereof for vaccine purposesINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sandra Zurawski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →